134
Views
18
CrossRef citations to date
0
Altmetric
Review

Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease

Pages 1631-1639 | Accepted 15 Aug 2005, Published online: 09 Sep 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Falko Biedermann & W Wolfgang Fleischhacker. (2011) Emerging drugs for schizophrenia. Expert Opinion on Emerging Drugs 16:2, pages 271-282.
Read now
Joseph T. Coyle, Darrick Balu, Michael Benneyworth, Alo Basu & Alexander Roseman. (2010) Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues in Clinical Neuroscience 12:3, pages 359-382.
Read now

Articles from other publishers (16)

Clifford M. Cassidy, Joseph Therriault, Tharick A. Pascoal, Victoria Cheung, Melissa Savard, Lauri Tuominen, Mira Chamoun, Adelina McCall, Seyda Celebi, Firoza Lussier, Gassan Massarweh, Jean-Paul Soucy, David Weinshenker, Christine Tardif, Zahinoor Ismail, Serge Gauthier & Pedro Rosa-Neto. (2022) Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease. Neuropsychopharmacology 47:5, pages 1128-1136.
Crossref
Shefali Chaudhary, Simon Zhornitsky, Herta H. Chao, Christopher H. van Dyck & Chiang-Shan R. Li. (2022) Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology. American Journal of Alzheimer's Disease & Other Dementias® 37, pages 153331752210828.
Crossref
Francesca Alemanno & Fernando Alemanno. 2020. Biochemistry for Anesthesiologists and Intensivists. Biochemistry for Anesthesiologists and Intensivists 123 138 .
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration 325 357 .
Yuan Dong, Xiaoheng Li, Jinbo Cheng & Lin Hou. (2019) Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?. International Journal of Molecular Sciences 20:3, pages 558.
Crossref
Anna Więckowska, Marcin Kołaczkowski, Adam Bucki, Justyna Godyń, Monika Marcinkowska, Krzysztof Więckowski, Paula Zaręba, Agata Siwek, Grzegorz Kazek, Monika Głuch-Lutwin, Paweł Mierzejewski, Przemysław Bienkowski, Halina Sienkiewicz-Jarosz, Damijan Knez, Tomasz Wichur, Stanislav Gobec & Barbara Malawska. (2016) Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 124, pages 63-81.
Crossref
Gianfranco Spalletta, Walter Gianni, Franco Giubilei, Anna R. Casini, Giuseppe Sancesario, Carlo Caltagirone & Luca Cravello. (2013) Rivastigmine Patch Ameliorates Depression in Mild AD. Alzheimer Disease & Associated Disorders 27:3, pages 289-291.
Crossref
Raquel Cuevas Pérez & Pilar de Azpiazu Artigas. 2011. Rehabilitación Neuropsicológica. Rehabilitación Neuropsicológica 363 e59 .
Zhe Jin, Liu Yang, Si-Jie Liu, Jian Wang, Shuo Li, Huang-Quan Lin, David Chi Cheong Wan & Chun Hu. (2010) Synthesis and biological evaluation of 3,6-diaryl-7H-thiazolo[3,2-b] [1,2,4]triazin-7-one derivatives as acetylcholinesterase inhibitors. Archives of Pharmacal Research 33:10, pages 1641-1649.
Crossref
QingChuan Zheng, HuiYing Chu, RuiJuan Niu & ChiaChung Sun. (2009) Theoretical studies of interaction models of human acetylcholine esterase with different inhibitors. Science in China Series B: Chemistry 52:11, pages 1911-1916.
Crossref
Susan BookheimerAlison Burggren. (2009) APOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive Aging. Annual Review of Clinical Psychology 5:1, pages 343-362.
Crossref
Stefania Butini, Giuseppe Campiani, Marianna Borriello, Sandra Gemma, Alessandro Panico, Marco Persico, Bruno Catalanotti, Sindu Ros, Margherita Brindisi, Marianna Agnusdei, Isabella Fiorini, Vito Nacci, Ettore Novellino, Tatyana Belinskaya, Ashima Saxena & Caterina Fattorusso. (2008) Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors. Journal of Medicinal Chemistry 51:11, pages 3154-3170.
Crossref
Jeffrey Kao & George Grossberg. 2008. Alzheimer's Disease. Alzheimer's Disease 25 51 .
Pedro Gil, José Regidor, Enrique Arriola, José Augusto García & Isidoro Ruipérez. (2007) La demencia en España: evolución desigual entre las necesidades de los pacientes y la oferta asistencial desde la geriatría. Revista de Calidad Asistencial 22:5, pages 234-242.
Crossref
S. V. Frankfort, B. A. Appels, A. De Boer, L. R. Tulner, J. P. C. M. Van Campen, C. H. W. Koks & J. H. Beijnen. (2006) Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting. International Journal of Clinical Practice 60:6, pages 646-654.
Crossref
. (2006) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 21:5, pages 500-507.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.